drugset

drugset / Trial / NCT00603473

A Phase III Open-Label Study Of Gabapentin As Adjunctive Therapy In Japanese Pediatric Patients With Partial Seizures

NCT00603473 ↗

Phase 3 Completed 92 enrolled Viatris Inc.

Non-randomizedSingle-groupOpen-labelTreatment

Summary

Examine the efficacy, safety and pharmacokinetics of gabapentin as adjunctive therapy in Japanese pediatric patients with partial seizures

Timeline

Start: 2008-01
Primary completion: 2009-12
Completion: 2009-12

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Gabapentin	Small molecule	—	Oral

Indications